49 filings
8-K
CELL
Bruker Cellular Analysis, Inc.
2 Oct 23
Completion of Acquisition or Disposition of Assets
8:47am
8-K
CELL
Bruker Cellular Analysis, Inc.
17 Aug 23
Entry into a Material Definitive Agreement
5:27pm
8-K
CELL
Bruker Cellular Analysis, Inc.
17 Aug 23
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
9:09am
8-K
CELL
Bruker Cellular Analysis, Inc.
14 Aug 23
PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update
4:09pm
8-K
CELL
Bruker Cellular Analysis, Inc.
7 Jul 23
Termination of a Material Definitive Agreement
4:15pm
8-K
a1nv0go7v sj37gyyr
23 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
lmndoh
26 May 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
vl4 97gsr9lxf0ndv
11 May 23
PhenomeX Reports First Quarter 2023 Financial Results
4:05pm
8-K
s2i5 se7ma6qpkyn
5 May 23
Cost Associated with Exit or Disposal Activities
5:26pm
8-K
yloku
28 Apr 23
Departure of Directors or Certain Officers
4:10pm
8-K
9n7y51zd00jg0ie3csmu
10 Apr 23
PhenomeX Appoints Peter Silvester to PhenomeX Board of Directors
9:43am
8-K
fbovk0nqg8zuincx
21 Mar 23
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
5:03pm
8-K
swrw4owljy15c
16 Mar 23
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
pgwlt evhu5stx3ao
10 Mar 23
Regulation FD Disclosure
5:30pm
8-K
0jkj3y7q
6 Mar 23
Unaudited Pro Forma Condensed Combined Financial Statements
4:43pm
8-K
b5qk6
23 Feb 23
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results
4:27pm
8-K
37pn48lef1qe8
14 Feb 23
Other Events
5:24pm
8-K
nn6ey7699oh9vi
26 Jan 23
Departure of Directors or Certain Officers
4:10pm
8-K
cujavnxwftzllld
9 Jan 23
Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
4:48pm
8-K
8pdz9s scz
21 Dec 22
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
5:27pm